Ameriprise’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.7M Buy
262,089
+44,029
+20% +$2.14M ﹤0.01% 1636
2025
Q1
$7.42M Buy
218,060
+12,887
+6% +$439K ﹤0.01% 1987
2024
Q4
$8.07M Buy
205,173
+18,412
+10% +$724K ﹤0.01% 1973
2024
Q3
$8.77M Buy
186,761
+23,884
+15% +$1.12M ﹤0.01% 1910
2024
Q2
$8.8M Buy
162,877
+6,096
+4% +$329K ﹤0.01% 1857
2024
Q1
$10.7M Buy
156,781
+28,887
+23% +$1.97M ﹤0.01% 1723
2023
Q4
$8M Buy
127,894
+12,520
+11% +$783K ﹤0.01% 1980
2023
Q3
$5.23M Sell
115,374
-13,945
-11% -$632K ﹤0.01% 2247
2023
Q2
$7.26M Buy
129,319
+45,941
+55% +$2.58M ﹤0.01% 2055
2023
Q1
$3.77M Buy
83,378
+25,994
+45% +$1.18M ﹤0.01% 2505
2022
Q4
$2.33M Sell
57,384
-46,985
-45% -$1.91M ﹤0.01% 2742
2022
Q3
$6.9M Buy
104,369
+45,237
+77% +$2.99M ﹤0.01% 1988
2022
Q2
$3.59M Buy
59,132
+5,296
+10% +$322K ﹤0.01% 2509
2022
Q1
$3.38M Buy
53,836
+7,909
+17% +$496K ﹤0.01% 2666
2021
Q4
$3.48M Sell
45,927
-290,766
-86% -$22M ﹤0.01% 2700
2021
Q3
$37.7M Sell
336,693
-77
-0% -$8.62K 0.01% 889
2021
Q2
$54.5M Sell
336,770
-129,522
-28% -$21M 0.02% 759
2021
Q1
$56.8M Buy
466,292
+17,396
+4% +$2.12M 0.02% 721
2020
Q4
$68.5M Sell
448,896
-181,267
-29% -$27.7M 0.02% 602
2020
Q3
$52.6M Sell
630,163
-436,415
-41% -$36.4M 0.02% 619
2020
Q2
$78.4M Buy
1,066,578
+250,371
+31% +$18.4M 0.03% 464
2020
Q1
$34.6M Buy
816,207
+346,434
+74% +$14.7M 0.02% 677
2019
Q4
$28.6M Buy
469,773
+449,202
+2,184% +$27.4M 0.01% 959
2019
Q3
$843K Sell
20,571
-37
-0.2% -$1.52K ﹤0.01% 3086
2019
Q2
$971K Sell
20,608
-3,279
-14% -$154K ﹤0.01% 3074
2019
Q1
$853K Buy
23,887
+1,214
+5% +$43.4K ﹤0.01% 3092
2018
Q4
$648K Sell
22,673
-25,827
-53% -$738K ﹤0.01% 3100
2018
Q3
$2.15M Sell
48,500
-3,902
-7% -$173K ﹤0.01% 2790
2018
Q2
$2.99M Buy
52,402
+25,269
+93% +$1.44M ﹤0.01% 2547
2018
Q1
$1.17M Buy
+27,133
New +$1.17M ﹤0.01% 2905